Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling

J Hepatol. 2013 Apr;58(4):840-2. doi: 10.1016/j.jhep.2012.08.029. Epub 2012 Dec 13.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Female
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / genetics*
  • Hepatitis C, Chronic / virology*
  • Humans
  • Interleukins / genetics*
  • Male
  • Polymorphism, Single Nucleotide*

Substances

  • Interleukins